Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Erpeng Yang"'
Autor:
Cheng Wang, Dong Xu, Jianjun Liu, Gang Huang, Haitao Zhao, You Zhang, Jonathan W Engle, Min Cao, Yanfei Wu, Sara Malih, Erpeng Yang, Muhsin H Younis, Wilson Lin, Qiufang Liu, Mohammad J Rasaee, Yihui Guan, Weibo Cai, Fang Xie, Weijun Wei
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 4 (2024)
Background The programmed cell death protein-1 (PD-1)/programmed death receptor ligand 1 (PD-L1) axis critically facilitates cancer cells immune evasion. Antibody therapeutics targeting the PD-1/PD-L1 axis have shown remarkable efficacy in various tu
Externí odkaz:
https://doaj.org/article/262453d2de77497ea1faf8ccb3c68f7d
Autor:
Erpeng Yang, Yan Lv, Ziqing Wang, Dehao Wang, Yumeng Li, Yan Sun, Yanyu Zhang, Jicong Niu, Zhuo Chen, Weiyi Liu, Xiaomei Hu
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
ObjectivesThe currently recommended aspirin regimen appears inadequate for thromboprophylaxis in essential thrombocythemia (ET). This study aimed not only to evaluate the curative effect of aspirin but also to explore the coagulation status and deter
Externí odkaz:
https://doaj.org/article/3dee6c8cb52145f7a015c7dfa5d345d2
Autor:
Jing Ming, Weiyi Liu, Hongwei Wu, Yujin Li, Erpeng Yang, Ziqing Wang, Haiyan Xiao, Richeng Quan, Xiaomei Hu
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 140, Iss , Pp 111767- (2021)
Background: Polycythemia vera (PV) is a refractory hematological disease that lack of effective therapy. Chinese traditional medicine Longchai Jiangxue formula (LCJX) has showed the powerful effects on PV. However, the active ingredients and mechanis
Externí odkaz:
https://doaj.org/article/94961ea1bc39456da22f154ab0f85723
Autor:
Ziqing Wang, Yan Lv, Erpeng Yang, Yujin Li, Dehao Wang, Guang Hu, Yumeng Li, Mingjing Wang, Weiyi Liu, Mingqian Sun, Xiaomei Hu
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4913
Polycythemia vera (PV) is a malignant clonal hematological disease of hematopoietic stem cells characterized by the proliferation of peripheral blood cells, and JAK2 mutation is one of the main causes of PV peripheral blood cell proliferation. Abnorm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::839c75fe493922e26c1fdba2be910807
Autor:
Jing Ming, Richeng Quan, Yujin Li, Mingjing Wang, Ziqing Wang, Xueying Wang, Haiyan Xiao, Erpeng Yang, Xiao-Mei Hu, Weiyi Liu
Publikováno v:
Annals of Hematology
To assess the effects between MPL and JAK2V617F on the thrombosis risk and peripheral blood cell counts in patients with essential thrombocythemia (ET), we identified eligible studies from PubMed, Embase, and the Cochrane Library. Seven studies were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fff9e6e703f547edaf456574d95cb7c6
https://doi.org/10.1007/s00277-021-04617-6
https://doi.org/10.1007/s00277-021-04617-6
Publikováno v:
Blood. 140:12252-12253
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::309fd0f6a0502929ccb0b01a69ac605e
https://doi.org/10.1182/blood-2022-164526
https://doi.org/10.1182/blood-2022-164526
Autor:
Dehao Wang, Pei Zhao, Yan Lv, Jing Ming, Ziqing Wang, Erpeng Yang, Yumeng Li, Mingjing Wang, Jicong Niu, Yanyu Zhang, Yan Sun, Yi Chen, Ke Chen, Zhuo Chen, Weiyi Liu, Xiaomei Hu
Publikováno v:
Journal of Clinical Medicine
Volume 12
Issue 3
Pages: 1078
Volume 12
Issue 3
Pages: 1078
Abnormal platelet activation can lead to thrombosis in essential thrombocythemia (ET) and thus impact patient prognosis. Platelet activation-associated proteins are key molecules for platelet activation. However, it is unclear which proteins are most
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6244aa04b01bfb9a58e3c06e355da203
https://doi.org/10.3390/jcm12031078
https://doi.org/10.3390/jcm12031078
Publikováno v:
Drug discovery today. 27(6)
In recent years, nanobodies have emerged as ideal imaging agents for molecular imaging. Molecular nanobody imaging combines the specificity of nanobodies with the sensitivity of state-of-the-art molecular imaging modalities, such as positron emission
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e82714053f947c3a1e348b748f066b2
https://pubmed.ncbi.nlm.nih.gov/35331925
https://pubmed.ncbi.nlm.nih.gov/35331925
Autor:
Ziqing Wang, Weiyi Liu, Dehao Wang, Erpeng Yang, Yujin Li, Yumeng Li, Yan Sun, Mingjing Wang, Yan Lv, Xiaomei Hu
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 22; Pages: 6615
Thrombosis is a common complication of myeloproliferative neoplasm (MPN), and it is a major cause of disability and death. With the development of next-generation gene-sequencing technology, the relationship between non-driver mutations and thromboti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fde59171c04b0cccd49f9cbfa967307
https://doi.org/10.3390/jcm11226615
https://doi.org/10.3390/jcm11226615
Autor:
Zi-Qing Wang, Xiao-Mei Hu, Yujin Li, Weiyi Liu, Xueying Wang, Mingjing Wang, Jing Ming, Erpeng Yang, Richeng Quan
Publikováno v:
Annals of Hematology
Additional sex combs like 1 (ASXL1) mutations are one of the most common molecular biological abnormalities in patients with primary myelofibrosis (PMF), and the effect of these mutations on prognosis remains controversial. Hence, we conducted a meta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfc72ff1184d7a218e778546616ffe0d
https://pubmed.ncbi.nlm.nih.gov/33386934
https://pubmed.ncbi.nlm.nih.gov/33386934